Personalized LASIK Surgery Market (2024 - 2030)

Personalized LASIK Surgery Market Trends

The global personalized LASIK surgery market size was valued at USD 3.85 billion in 2023 and is expected to grow at a CAGR of 4.9% from 2024 to 2030. The growing geriatric population has significantly increased the demand for corrective eye surgery to combat the increasing prevalence of vision problems such as hyperopia, myopia, and astigmatism. This demographic trend is further driving the demand for personalized LASIK procedures.

Another significant market driver is the increasing prevalence of cataracts. Cataracts are a common eye condition, which affects millions of people globally. Although cataract surgery remains the primary treatment, personalized LASIK procedures are gaining traction as an alternative. Patients with cataracts often seek LASIK surgery to address other refractive errors simultaneously, augmenting market expansion.

In addition, technological innovations in laser technology and diagnostic tools have enhanced the accuracy and safety of personalized LASIK. Patients have become increasingly aware of the efficacy and safety of these procedures which has led to higher adoption. This has also contributed to the rising number of eye care centers worldwide that have made LASIK surgery more accessible. These centers offer personalized LASIK services, making it easier for patients to undergo vision correction procedures.

Type Insights

Wavefront guided LASIK surgeries have dominated the segment with 32.3% of the market share in 2023. Advanced wavefront technology is used to create a detailed map of the patient’s eyes, in these surgeries. This personalized data allows surgeons to tailor the laser treatment precisely, correcting common refractive errors such as myopia and hyperopia, and subtle irregularities for better patient outcomes. In addition, wavefront guided LASIK surgeries address higher-order aberrations (HOAs) which can cause issues including glare, halos, and reduced contrast sensitivity. With customized ablation patterns, wavefront guided LASIK minimizes these visual disturbances, leading to clearer, sharper vision. Surgeries increasingly prefer this surgery type to predict accurately, reducing the risk of overcorrection, and under-correction.

Wavefront optimized LASIK surgeries are expected to emerge as the fastest-growing segment during the forecast period as they combine the benefits of traditional LASIK with personalized adjustments. Such surgeries optimize treatment based on the patient’s unique corneal curvature, minimizing aberrations. They preserve the natural corneal shape, enhance visual quality, and reduce side effects. In addition, wavefront optimized LASIK minimizes HOAs. They maintain the cornea’s natural symmetry and prevent visual disturbances such as glare and halos.

Application Insights

Myopia secured the dominant market share in 2023 owing to its growing incidence among patients of all ages. People with myopia can see nearby objects clearly but experience blurriness when looking at distant objects. LASIK surgery effectively eliminates this near focus caused by myopia. Hence, it has increasingly become a sought-after solution for vision correction. Moreover, personalized treatments have gained popularity as patients become progressively informed about LASIK options. The availability of advanced instruments and the rising number of eye care centers offering personalized LASIK surgeries further drive adoption. Patients seek precise, customized solutions for their myopia, contributing to market growth.

Presbyopia is expected to grow substantially at a CAGR of 5.4% during the forecast period. Presbyopia, a condition where the eye’s ability to focus on nearby objects diminishes with age, has significantly driven the demand for precise treatments such as personalized LASIK. Additionally, the advent of advanced instruments and diagnostic tools has enhanced the accuracy and safety of these surgeries. They offer improved visual quality, reduce dependence on eyewear, and ensure faster recovery. Surgeons can tailor treatments to address Presbyopia-related visual changes, ensuring better outcomes.

End Use Insights

Hospitals registered the dominant market share in 2023 owing to the rising prevalence of vision problems among the growing geriatric population. Elderly individuals have increasingly sought corrective eye surgeries including LASIK to improve their vision. As hospitals are primary healthcare providers, the market witnessed a significant demand for personalized LASIK procedures performed in hospitals. Additionally, hospitals have increasingly collaborated with eye care centers to provide personalized LASIK services to patients.

Ambulatory surgical centers (ASCs) are projected to emerge as the fastest-growing segment at a CAGR of 5.4% over the forecast period as these centers cater to the increasing demand for minimally invasive procedures. Patients prefer these centers due to their convenience, shorter recovery times, and reduced costs compared to hospitals, without compromising quality. In addition, ASCs adopt advanced surgical devices and equipment including innovative laser technology, diagnostic tools, and personalized treatment planning. This has further enhanced the precision and safety of LASIK procedures, driving market growth.

Regional Insights

The North America personalized LASIK surgery market held the dominant share of the market with 41.2% in 2023. The market was primarily driven by the growing geriatric population who increasingly seek correct eye surgery including LASIK to improve their vision. Moreover, the rising number of eye care centers across the region offer personalized LASIK services, thereby making the surgery more accessible.

U.S. Personalized LASIK Surgery Market Trends

The personalized LASIK surgery market in the U.S. was propelled by patients increasingly seeking personalized procedures as an alternative to cataract surgeries. With a large and diverse population, the country presented a significant patient pool increasingly inclining toward minimally invasive surgeries. Patients appreciate advantages such as shorter hospital stays and reduced blood loss, contributing to the market growth.

Europe Personalized LASIK Surgery Market Trends

The Europe personalized LASIK surgery market accounted for 30.5% of the market share in 2023 owing to the prevalence of myopia (nearsightedness) and presbyopia (age-related farsightedness). As a result, European residents have increasingly demanded minimally invasive procedures such as personalized LASIK. In addition, the region’s healthcare systems often provide favorable reimbursement policies for eye surgeries. This encourages patients to seek personalized LASIK treatments, further driving market expansion.

Asia Pacific Personalized LASIK Surgery Market Trends

The personalized LASIK surgery market in Asia Pacific (APAC) region registered for a share of 20.4% in 2023. The region has significantly benefited from susceptible, fast, and user-friendly technologically advanced tools. These innovations enhance the precision and safety of personalized LASIK procedures, attracting patients seeking effective vision correction through minimally invasive operations.

Key Personalized LASIK Surgery Company Insights

The global personalized LASIK surgery market is highly consolidated. Companies operating in the market such as Alcon Laboratories, Inc., Carl Zeiss, Inc., and Johnson & Johnson are indulging in heavy investments in R&D activities, acquisitions, and mergers to retain their dominant footprint.

• Alcon Laboratories, Inc., an eye care company, manufactures and distributes a wide range of eye care products, including ophthalmic solutions, eye drops, contact lens solutions, and eye vitamins. The company is committed to innovation and hence drives continuous development of new treatments and technologies.

• Carl Zeiss, Inc. is a player in the optical and optoelectronic industries. The company manufactures eyeglass lenses, camera lenses, cine lenses, and binoculars. Their optical and optoelectronic instruments cater to a wide range of applications, from ophthalmology to industrial metrology.

Recent Development

• In June 2024, Alcon Laboratories announced that the UNITY Vitreoretinal Cataract System (VCS) and UNITY Cataract System (CS) have received U.S. Food and Drug Administration (FDA) 510(k) clearance. This marks the debut of Alcon’s Unity portfolio.

Personalized LASIK Surgery